Skip to main content
Home

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

  • Read more about A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

Most cardiologists would take a lower salary for a better work-life balance

A majority of U.S. cardiologists would accept a cut in pay to achieve a significantly better work-life balance.

According to the same report, 43% of cardiologists with children said they feel conflicted about not spending enough time at home.

  • Read more about Most cardiologists would take a lower salary for a better work-life balance

Swiss startup targets stroke patients with first US install of robotics system for remote vascular interventions

Nanoflex Robotics, a healthcare technology startup based out of Switzerland, has installed its remote-ready robotics system for neurovascular procedures in the United States for the first time

Nanoflex Robotics representatives pose with Adnan Siddiqui, MD, PhD, CEO of The Jacobs Institute.

The new-look robotics system can help specialists perform remote mechanical thrombectomies from bedside or as far as thousands of miles away. 

  • Read more about Swiss startup targets stroke patients with first US install of robotics system for remote vascular interventions

Imaging firm finally executes merger following lawsuit and months of delays

healthcare money economics dollar stethoscope acquire merger

Investment firm GigCapital Global announced the finalization of its acquisition of QT Imaging on March 4. 

  • Read more about Imaging firm finally executes merger following lawsuit and months of delays

Neuroradiologists support bipartisan bill that would tap foreign physicians to relieve staffing shortages

The Healthcare Workforce Resilience Act would recapture 15,000 unused immigrant visas, previously authorized by Congress, for overseas medical doctors.

  • Read more about Neuroradiologists support bipartisan bill that would tap foreign physicians to relieve staffing shortages

RadNet announces plan to raise $200M through another public stock offering

GE has completed the spinoff of its healthcare business, and GE HealthCare began trading as its own entity on the Nasdaq Jan. 4. Stock Market

Proceeds from the share sale will go toward potential future acquisitions and other “general corporate purposes,” the imaging group said Thursday. 

  • Read more about RadNet announces plan to raise $200M through another public stock offering

Radiology provider Affidea acquires 4-location cancer care outfit

affidea

Backed by investment firm Groupe Bruxelles Lambert, Europe's largest diagnostic imaging provider has a deal to acquire a Romanian radiotherapy firm.  

  • Read more about Radiology provider Affidea acquires 4-location cancer care outfit

Sectra signs $20.4M enterprise imaging contract with academic health system

Sectra radiology solution

Sectra's radiology solution

The unnamed U.S. university conducts about 2 million imaging exams each year across more than 10 hospitals. 

  • Read more about Sectra signs $20.4M enterprise imaging contract with academic health system

Change Healthcare cyberattack: A recap and update in 10 quotes

change healthcare cyberattack

Photo by Hacker Noon via Unsplash

“This is what happens when everything merges and you only have one option.”

  • Read more about Change Healthcare cyberattack: A recap and update in 10 quotes

Some older patients taking aspirin to prevent CVD may be doing more harm than good

Patients who take diuretics, renin-angiotensin system (RAD) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) at the same time face a much higher risk of developing acute kidney injury (AKI)

“Aspirin is no longer a one-size-fits-all preventive tool for older adults," according to one specialist with Michigan Medicine. 

  • Read more about Some older patients taking aspirin to prevent CVD may be doing more harm than good

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …654
    • Page 655
    • Page 656
    • Page 657
    • Current page 658
    • Page 659
    • Page 660
    • Page 661
    • Page 662 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme